Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Genpharmasec Ltd (NSE: GENPHARMA), ISIN INE861N01036 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GENPHARMA last traded at ₹1.15 (+0.88%), with a 52-week range of ₹0.75 to ₹2.02 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 29.98%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 37/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.